Expected headings
"Diagnostic criteria"
"which is not primarily due to another cause, such as left ventricular dysfunction, sepsis, hypovolaemia or an arrhythmia"
"Intravenous administration of systemic thrombolytics, such as recombinant tissue type plasminogen activator (rtPA), may be considered. Systemic administration may be preferable to catheter-directed thrombolysis, although this remains controversial. Thrombolytic administration may reduce the clot burden, resulting in an improvement in haemodynamics; however, there is an attendant risk of major arterial bleeding. Absolute contraindications to systemic thrombolytic administration include the following: 7"